𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Successful treatment of reactive arthritis with a humanized anti–interleukin-6 receptor antibody, tocilizumab

✍ Scribed by Tanaka, Toshio ;Kuwahara, Yusuke ;Shima, Yoshihito ;Hirano, Toru ;Kawai, Mari ;Ogawa, Masako ;Arimitsu, Junsuke ;Hagihara, Keisuke ;Narazaki, Masashi ;Ogata, Atsushi ;Kawase, Ichiro ;Kishimoto, Tadamitsu

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
113 KB
Volume
61
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful use of a humanized anti–inter
Successful use of a humanized anti–interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis
✍ Yasuaki Okuda; Kiyoshi Takasugi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB 👁 1 views

## Abstract We report an excellent clinical response to treatment with a humanized anti–interleukin‐6 receptor antibody, tocilizumab, in a patient with progressive amyloid A (AA) amyloidosis complicating very active juvenile idiopathic arthritis. Treatment with tocilizumab immediately normalized th

Treatment of rheumatoid arthritis with h
Treatment of rheumatoid arthritis with humanized anti–interleukin-6 receptor antibody: A multicenter, double-blind, placebo-controlled trial
✍ Norihiro Nishimoto; Kazuyuki Yoshizaki; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Sh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

## Abstract ## Objective Interleukin‐6 (IL‐6) is a pleiotropic cytokine that regulates the immune response, inflammation, and hematopoiesis. Overproduction of IL‐6 plays pathologic roles in rheumatoid arthritis (RA), and the blockade of IL‐6 may be therapeutically effective for the disease. This s